1. Cutaneous immune‐related adverse events in patients with melanoma treated with checkpoint inhibitors. (1st August 2021) Authors: Gault, A.; Anderson, A.E.; Plummer, R.; Stewart, C.; Pratt, A.G.; Rajan, N. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous immune‐related adverse events in patients with melanoma treated with checkpoint inhibitors. (1st February 2021) Authors: Gault, A.; Anderson, A.E.; Plummer, R.; Stewart, C.; Pratt, A.G.; Rajan, N. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. North East England outcomes in node positive breast cancer from the real world use of 21 gene recurrence score testing. (November 2022) Authors: Gault, A.; Veeratterpillay, J.; Taylor, W. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Review of outcomes for patients with large cell neuroendocrine lung tumours in North East England. (January 2019) Authors: Gault, A.; Greystoke, A.; Hughes, A.; Gardiner, J. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Review of Outcomes in North East England for Patients Receiving Neoadjuvant Chemotherapy for Breast Carcinoma. Issue 8 (August 2020) Authors: Gault, A.; Dobeson, C.; Haney, S.; Graham, J.; Humphreys, A. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗